BLOG

In my previous blog and article, I raised concerns about how a lack of compassion negatively impacts patient care. When patients perceive that they’re not being heard or their concerns are not taken seriously by their physicians, it can have deleterious effects on whether they’ll follow “doctor’s orders” for a

Do You Have Self-Compassion? Beat the Need to be a Perfectionist I really prefer to work with people who pay close attention to details. They are quite conscientious of their work. In fact, not only do I look for these types of individuals when I hire people, but my Personnel Selection

Imagine having a conversation with your future self, getting insights on avoiding pitfalls on your life’s journey. Philosophers have known for thousands of years why we need to live life forward yet with a strong need to understand our past. The new book, Your Future Self, by UCLA Professor Hal

Since Vision2Voice opened our doors in 2008, I’ve been both honored and humbled over these past 15 years. Looking back on my personal and professional growth as a business leader, as well as a colleague, mentor, and friend, I’ve learned many lessons along the way. Here are just a few:

We’ve been hearing a lot about how a new kind of pharma marketing organization is emerging. Driven by deeper personalization and powered by technology, here are a few trends and links to relevant articles of interest:  Source: ZS.com In our daily lives, we’re all customers. We have more information than

While clinical excellence is the ultimate driver of positive outcomes, compassion can add significant value to those outcomes in measurable ways. What is compassion? Most scientists agree that compassion is the emotional response to another’s pain or suffering, involving an authentic desire to help. Compassion is included in the American

Pharmaceutical marketing has changed dramatically over the past two decades. The Office of Inspector General’s (OIG’s) Special Fraud Alert mandated tighter controls over peer-to-peer speaker programs. The Sunshine Act required greater transparency into monetary transactions between pharma manufacturers and healthcare providers (HCPs). Direct access to HCPs has declined steadily, with